share_log

Helius Medical Technologies Expands Stroke Clinical Program With Participation Of Shepherd Center

Benzinga ·  Apr 24 21:23

-- Helius Medical and Shepherd Center partner on a study that aims at rehabilitating walking mobility in people recovering from stroke --

-- Shepherd Center, a top neurorehabilitation hospital, is the third site in Helius' U.S. registrational program for Portable Neuromodulation Stimulator (PoNS) in stroke --

-- The single-arm study will evaluate PoNS in treating gait and balance deficits in chronic stroke survivors --

-- Regulatory submission seeking marketing authorization for stroke expected in 2025--

NEWTOWN, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits...

Login or create a forever free account to read this news
Sign up/Log in
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment